Literature DB >> 23093777

HELLP babies link a novel lincRNA to the trophoblast cell cycle.

Marie van Dijk1, Hari K Thulluru, Joyce Mulders, Omar J Michel, Ankie Poutsma, Sandra Windhorst, Gunilla Kleiverda, Daoud Sie, Augusta M A Lachmeijer, Cees B M Oudejans.   

Abstract

The HELLP syndrome is a pregnancy-associated disease inducing hemolysis, elevated liver enzymes, and low platelets in the mother. Although the HELLP symptoms occur in the third trimester in the mother, the origin of the disease can be found in the first trimester fetal placenta. A locus for the HELLP syndrome is present on chromosome 12q23 near PAH. Here, by multipoint nonparametric linkage, pedigree structure allele sharing, and haplotype association analysis of affected sisters and cousins, we demonstrate that the HELLP locus is in an intergenic region on 12q23.2 between PMCH and IGF1. We identified a novel long intergenic noncoding RNA (lincRNA) transcript of 205,012 bases with (peri)nuclear expression in the extravillous trophoblast using strand-specific RT-PCR complemented with RACE and FISH. siRNA-mediated knockdown followed by RNA-sequencing, revealed that the HELLP lincRNA activated a large set of genes that are involved in the cell cycle. Furthermore, blocking potential mutation sites identified in HELLP families decreased the invasion capacity of extravillous trophoblasts. This is the first large noncoding gene to be linked to a Mendelian disorder with autosomal-recessive inheritance.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23093777      PMCID: PMC3484460          DOI: 10.1172/JCI65171

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  25 in total

1.  An Australian twin study of the genetic basis of preeclampsia and eclampsia.

Authors:  S A Treloar; D W Cooper; S P Brennecke; M M Grehan; N G Martin
Journal:  Am J Obstet Gynecol       Date:  2001-02       Impact factor: 8.661

2.  Optimal allele-sharing statistics for genetic mapping using affected relatives.

Authors:  M S McPeek
Journal:  Genet Epidemiol       Date:  1999       Impact factor: 2.135

3.  The structure of haplotype blocks in the human genome.

Authors:  Stacey B Gabriel; Stephen F Schaffner; Huy Nguyen; Jamie M Moore; Jessica Roy; Brendan Blumenstiel; John Higgins; Matthew DeFelice; Amy Lochner; Maura Faggart; Shau Neen Liu-Cordero; Charles Rotimi; Adebowale Adeyemo; Richard Cooper; Ryk Ward; Eric S Lander; Mark J Daly; David Altshuler
Journal:  Science       Date:  2002-05-23       Impact factor: 47.728

4.  A high-resolution recombination map of the human genome.

Authors:  Augustine Kong; Daniel F Gudbjartsson; Jesus Sainz; Gudrun M Jonsdottir; Sigurjon A Gudjonsson; Bjorgvin Richardsson; Sigrun Sigurdardottir; John Barnard; Bjorn Hallbeck; Gisli Masson; Adam Shlien; Stefan T Palsson; Michael L Frigge; Thorgeir E Thorgeirsson; Jeffrey R Gulcher; Kari Stefansson
Journal:  Nat Genet       Date:  2002-06-10       Impact factor: 38.330

5.  Haploview: analysis and visualization of LD and haplotype maps.

Authors:  J C Barrett; B Fry; J Maller; M J Daly
Journal:  Bioinformatics       Date:  2004-08-05       Impact factor: 6.937

6.  Efficient, rapid and reliable establishment of human trophoblast cell lines using poly-L-ornithine.

Authors:  M Y Choy; G St Whitley; I T Manyonda
Journal:  Early Pregnancy       Date:  2000-04

7.  A genome-wide scan for preeclampsia in the Netherlands.

Authors:  A M Lachmeijer; R Arngrímsson; E J Bastiaans; M L Frigge; G Pals; S Sigurdardóttir; H Stéfansson; B Pálsson; D Nicolae; A Kong; J G Aarnoudse; J R Gulcher; G A Dekker; L P ten Kate; K Stéfansson
Journal:  Eur J Hum Genet       Date:  2001-10       Impact factor: 4.246

Review 8.  Pre-eclampsia.

Authors:  Baha Sibai; Gus Dekker; Michael Kupferminc
Journal:  Lancet       Date:  2005 Feb 26-Mar 4       Impact factor: 79.321

9.  Plasma placenta growth factor levels in midtrimester pregnancies.

Authors:  M L Tjoa; J M van Vugt; M A Mulders; R B Schutgens; C B Oudejans; I J van Wijk
Journal:  Obstet Gynecol       Date:  2001-10       Impact factor: 7.661

Review 10.  HELLP syndrome: the state of the art.

Authors:  Jason K Baxter; Louis Weinstein
Journal:  Obstet Gynecol Surv       Date:  2004-12       Impact factor: 2.347

View more
  39 in total

Review 1.  Targeting long non-coding RNA to therapeutically upregulate gene expression.

Authors:  Claes Wahlestedt
Journal:  Nat Rev Drug Discov       Date:  2013-06       Impact factor: 84.694

2.  Chromosome conformation capture-on-chip analysis of long-range cis-interactions of the SOX9 promoter.

Authors:  Marta Smyk; Przemyslaw Szafranski; Michał Startek; Anna Gambin; Paweł Stankiewicz
Journal:  Chromosome Res       Date:  2013-11-20       Impact factor: 5.239

Review 3.  Beyond GWASs: illuminating the dark road from association to function.

Authors:  Stacey L Edwards; Jonathan Beesley; Juliet D French; Alison M Dunning
Journal:  Am J Hum Genet       Date:  2013-11-07       Impact factor: 11.025

Review 4.  Adaptive mechanisms controlling uterine spiral artery remodeling during the establishment of pregnancy.

Authors:  Michael J Soares; Damayanti Chakraborty; Kaiyu Kubota; Stephen J Renaud; M A Karim Rumi
Journal:  Int J Dev Biol       Date:  2014       Impact factor: 2.203

Review 5.  Long noncoding RNAs: a potent source of regulation in immunity and disease.

Authors:  Albert D Yu; Zichen Wang; Kevin V Morris
Journal:  Immunol Cell Biol       Date:  2015-03       Impact factor: 5.126

6.  Genetic "lnc"-age of noncoding RNAs to human disease.

Authors:  Andrew Troy; Norman E Sharpless
Journal:  J Clin Invest       Date:  2012-10-24       Impact factor: 14.808

Review 7.  Long non-coding RNA regulation of reproduction and development.

Authors:  David H Taylor; Erin Tsi-Jia Chu; Roman Spektor; Paul D Soloway
Journal:  Mol Reprod Dev       Date:  2015-10-30       Impact factor: 2.609

Review 8.  Long non-coding RNA in health and disease.

Authors:  Philipp G Maass; Friedrich C Luft; Sylvia Bähring
Journal:  J Mol Med (Berl)       Date:  2014-02-16       Impact factor: 4.599

Review 9.  Long non-coding RNAs as novel targets for therapy in hepatocellular carcinoma.

Authors:  Mansi A Parasramka; Sayantan Maji; Akiko Matsuda; Irene K Yan; Tushar Patel
Journal:  Pharmacol Ther       Date:  2016-03-22       Impact factor: 12.310

Review 10.  Long noncoding RNAs: cellular address codes in development and disease.

Authors:  Pedro J Batista; Howard Y Chang
Journal:  Cell       Date:  2013-03-14       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.